U.S. Semiconductors  ·  Valuation Deep Dive

Micron —
even after modeling a real downcycle, I still get $1,300–$1,470

I wanted to see what Micron is actually worth if I stop looking only at peak FY27 earnings and explicitly model the next memory downcycle. So I rebuilt the valuation from scratch. The result: about $1,300/share from DCF and about $1,470/share from FY27–31 cycle-average earnings — even though my Base case assumes gross margin falls from 87% to a 60% trough by FY30.

MU · MICRON NASDAQ 22 August 2026 Japan Stock Alpha valuation model
Price Anchor
$940.76
18 Aug 2026 close · dated comparison point
Base DCF
~$1,300
11.5% WACC · 3.0% terminal growth
Cycle-Average P/E
~$1,470
FY27–31 avg EPS ~ $147 × 10x
Modeled Trough GM
60%
FY30 · real downcycle already included

I wanted to see what Micron is actually worth if I stop looking only at peak FY27 earnings and explicitly model the next memory downcycle.

So I rebuilt the valuation from scratch. This is my own analysis and valuation work — not investment advice.

I’ve tried to stay fairly conservative with the assumptions.

The result

DCF
~$1,300
per share
FY27–31 Cycle-Average P/E
~$1,470
per share at 10x
Upside vs. Dated Anchor
~38–56%
vs. $940.76 on Aug. 18, 2026
The part that matters
My Base already assumes Micron's gross margin falls from 87% in FY27 to 60% in FY30.

So the thesis is not that today's extraordinary margins last forever.

It is that the next trough may be structurally higher — and less destructive — than the memory cycles investors are used to.

Bar chart of Micron base case valuation per share: current price $941, DCF $1,300 and cycle-average P/E $1,470, an implied upside of 38-56%.
Japan Stock Alpha Base case valuation — $1,300–1,470 per share against a $941 price anchor, an implied 38–56% upside. The Base case already includes a 60% FY30 gross-margin trough.

1. Peak earnings are not the real debate

Micron's current numbers are extraordinary.

Fiscal Q3 revenue reached $41.46B, non-GAAP gross margin hit 84.9%, and non-GAAP EPS came in at $25.11. For fiscal Q4, management is guiding to roughly $50B of revenue, 86% gross margin and $31 of EPS. My FY27 Base is $267B of revenue, 87% GM and about $166 of EPS.

That sounds aggressive until you compare it with the Street.

FY27 estimateRevenueEPS
My Base$267B~$166
Morgan Stanley~$266.9B~$168.5
Barclays~$267.4B~$166.7
UBS~$184.9

In other words, FY27 is not where I am taking the heroic view. Morgan Stanley is almost exactly on my revenue and EPS. Barclays is similar. UBS is materially above me.

Micron's own commentary has become more bullish as well. At the August KeyBanc conference, management said customer demand signals had strengthened further and that calendar 2027 could be even tighter than 2026, because demand growth is running faster than supply growth.

That is why I think obsessing over whether FY27 EPS is $160, $166 or $175 misses the bigger issue.

The stock will not ultimately be valued on the peak. It will be valued on what happens after the peak.

2. Why this cycle may actually be different

Memory has not stopped being cyclical. High prices still encourage capacity. Capacity eventually catches demand. Pricing weakens. Margins compress.

That mechanism is alive and well.

The question is whether several structural changes have altered the severity of the next downturn. I think three deserve particular attention.

Strategic Customer Agreements

Micron has now signed 16 Strategic Customer Agreements, or SCAs, covering a meaningful portion of future DRAM and NAND demand.

The headline numbers are substantial — including roughly $100B of cumulative minimum-price revenue across 14 agreements and significant customer deposits and commitments.

But the more important point is what those contracts may do to the cycle.

More contracted demand → better utilization visibility → better pricing visibility → potentially better downturn profitability.

Micron has also said that price-band SCAs can still generate strong gross margins even at the contractual floor.

That does not mean Micron has created a company-wide gross-margin floor. Only part of the business is covered, contract structures differ, and most of the current agreements run through calendar 2030.

My interpretation is narrower: SCAs may make the next downturn less severe than previous memory cycles.

Micron SCA framework showing 16 signed SCAs, DRAM and NAND coverage, minimum-price revenue and deposits.
Source: Micron Q3 FY26 prepared remarks. SCA floor economics are not a company-wide gross-margin floor.

HBM changes the supply equation

HBM is usually discussed as a premium product.

I think the more important point is that it changes supply elasticity.

Micron itself says HBM requires more wafers and more cleanroom space to produce the same number of bits as conventional DRAM.

HBM demand rises → more capacity is absorbed per bit → less capacity is available for conventional DRAM → conventional supply stays tighter → pricing gets support.

This is one reason the AI memory cycle can spill over into ordinary DRAM economics.

It can also reverse. If HBM demand weakens and suppliers redirect capacity back into conventional DRAM, supply can increase quickly and pricing can fall.

That is not a footnote. It is probably one of the cleanest downside transmission mechanisms in the entire thesis.

The balance sheet is much stronger

At the end of fiscal Q3, Micron had approximately:

For a deeply cyclical, capital-intensive semiconductor company, that matters. A memory downturn is much more dangerous when the company enters it with high leverage and a large capex program that still has to be funded.

Micron is approaching the next cycle from a much stronger financial position.

Framework showing how HBM capacity intensity and strategic customer agreements could contribute to a higher Micron cycle trough.
Sources: Micron disclosures. Diagram shows Japan Stock Alpha interpretation.

This is not a thesis that Micron has become non-cyclical.

It is a thesis that the next trough may be less destructive.

3. The credit market is noticing too

On August 19, S&P Global Ratings raised Micron to BBB+ with a Positive outlook, from BBB.

The direct equity impact is easy to exaggerate. Micron has little net financial leverage, so moving from BBB to BBB+ does not suddenly take hundreds of basis points out of my WACC.

That is not why I care.

I care about what the rating action says about resilience.

When S&P upgraded Micron to BBB earlier this year, it highlighted AI-driven improvement in scale, EBITDA and cash flow, Micron's strong balance sheet, and the possibility that operating metrics could become less volatile if AI memory demand continues to outpace the industry's ability to add supply.

S&P was careful not to declare cyclicality dead. It explicitly kept severe AI-demand and memory-downturn risks in the framework.

The rating upgrade is not a direct stock catalyst. It is external validation that Micron's financial profile is stronger going into the next cycle.

Micron balance sheet and S&P ratings progression showing $30.2B cash and investments, $5.7B debt and $24.4B net cash.
Sources: Micron Q3 FY26; S&P Global Ratings.

There is also a second-order implication:

stronger cash flow → stronger balance sheet → better credit → more capital-allocation flexibility.

4. What are institutions actually debating?

The bigger disagreement is what happens after FY27. More specifically: how low margins fall in the next downturn.

Morningstar remains firmly in the traditional-cycle camp. It still expects a major downturn around 2029 and sees long-term gross margins in the 40–50% range.

Bernstein's earlier cycle work took a different route but reached a similar warning on duration: it modeled Micron GM falling from roughly 85.5% in FY27 to 70.3% in FY28. That forecast is now dated on absolute earnings, but the philosophy is still relevant — once supply catches up, extraordinary margins can normalize fast.

UBS sits much further toward the structural-reset camp. Timothy Arcuri has interpreted Micron's SCA economics as consistent with roughly 70–75% gross margins, well below the current peak but far above old-cycle economics.

Still, the range tells you what the market is really arguing about.

Institutional gross margin spectrum for Micron showing Morningstar, historical peak, Japan Stock Alpha trough and UBS interpretation.
The numbers are intentionally labeled by type because they are not directly comparable forecasts.

My model deliberately sits between the extremes. I do not assume Micron goes back to 40–50% immediately. I also do not underwrite a permanent 70–75% GM as Base.

5. My Base case: peak → downcycle → higher trough

Here is the model.

Fiscal YearRevenueGross MarginEPSFCFF
FY27$267B87%$166$149B
FY28$290B80%$164$148B
FY29$285B68%$135$119B
FY30$305B60%$126$116B
FY31$325B63%$142$139B

The shape matters more than the exact annual number.

FY27: peak-like economics.

FY28: still very strong, but normalization starts.

FY29–30: a real downcycle. I even model revenue declining in FY29.

FY30: the modeled trough at 60% GM.

FY31: only a modest recovery to 63%.

Why 63%?

Because I do not think a cyclical trough should automatically become the permanent terminal state. But I also do not want to assume an aggressive snapback.

Micron's previous full-year non-GAAP GM peak was 59.2% in FY2018. So 63% is only modestly above the old full-year peak and still well below the 70–75% structural interpretation on the bullish side of the Street.

Meanwhile, the supply side gives me a reason to put the downcycle in FY29–30 rather than pretend tightness lasts forever. Micron expects first wafer output from Idaho ID1 in mid-calendar 2027, meaningful shipments from Tongluo around mid-2027, and ID2 output in late 2028. More industry capacity should matter increasingly from there.

Micron FY27 to FY31 modeled EPS and gross margin path, showing FY27 peak, FY30 trough and FY31 recovery.
The exact cycle will not follow a neat annual line. The model is trying to capture peak → normalization → trough → modest recovery.

6. What is that worth?

I use two valuation methods in parallel.

Two independent valuation lenses
MethodKey assumptionImplied value / share
DCF11.5% WACC / 3.0% terminal growth~$1,300
Cycle-Average P/EFY27–31 avg EPS ~ $147 × 10x~$1,470

DCF: ~$1,300

The cash-flow forecast is already shown in the Base Case above, so the key question here is what those cash flows are worth today.

DCF assumptionBase
WACC11.5%
Terminal growth3.0%
Net cash~$24.4B
Diluted shares~1.15B
Implied value/share~$1,300

I also wanted to make sure the valuation was not being driven by an unusually favorable discount rate.

WACCDCF / Share
11.5%~$1,300
12.0%~$1,230
12.5%~$1,170

Even at a 12.0–12.5% WACC, the DCF remains above the $940.76 price anchor used in this analysis.

Cycle-Average P/E: ~$1,470

For the earnings-based valuation, I use the full FY27–31 average EPS rather than simply applying a multiple to FY27 peak earnings.

Fiscal YearFY27FY28FY29FY30FY31Average
EPS$166$164$135$126$142~$147

That five-year period deliberately captures the full cycle I am modeling: peak → normalization → downcycle → trough → initial recovery.

That is why I think the ~$147 average is a more useful earnings base than FY27 alone.

Cycle-Average P/EImplied Value / Share
9x~$1,320
10x~$1,470
11x~$1,610

My Base is 10x, which gives me approximately $1,470/share.

Putting the two together
DCF: ~$1,300
Cycle-average P/E: ~$1,470

My Base valuation range is therefore ~$1,300–$1,470/share.

The DCF asks what Micron's modeled cash flows are worth today. The P/E approach asks what investors might reasonably pay for earnings averaged across the modeled memory cycle.

Different methods, different assumptions — but both point to a value materially above the $940.76 price anchor used in this analysis.

And importantly, neither valuation requires Micron to sustain today's 85%+ gross margins indefinitely.

7. The most important sensitivity is not FY27

You can move FY27 revenue or GM around and change EPS by a few dollars. That matters for the next earnings print.

It matters much less for intrinsic value than the earnings duration.

Margin pathFY27 → FY31DCF / Share
Faster trough87% → 77% → 62% → 55% → 58%~$1,190
Base87% → 80% → 68% → 60% → 63%~$1,300
Higher trough87% → 83% → 74% → 66% → 65%~$1,360

That is the core debate.

Not whether FY27 EPS is $162 or $170.

But whether FY29–30 GM is closer to 50%, 60% or 70%.

Micron valuation sensitivity showing DCF under different gross-margin paths and 9x to 11x cycle-average P/E values.
The model cares much more about the next trough than another small FY27 beat.

8. One upside I am not modeling: buybacks

Micron’s stronger balance sheet creates another source of optionality: capital returns.

The company currently has only about $2.2B remaining under its existing repurchase authorization. Morgan Stanley has modeled a much larger buyback scenario for FY27–28, but that is not Micron guidance, and I do not include a major repurchase program in my Base valuation.

That distinction matters.

A buyback can increase EPS simply by reducing the share count. But EPS accretion is not automatically value creation — the price paid for the shares matters.

If Micron eventually uses excess cash to repurchase stock materially below intrinsic value, I would view that as incremental upside to the per-share economics.

My $1,300–$1,470 valuation range does not depend on a large buyback. If management eventually has both the cash generation and balance-sheet flexibility to repurchase shares attractively, that would be upside optionality rather than a pillar of the thesis.
Micron illustrative buyback economics showing the difference between EPS accretion and intrinsic-value accretion.
Illustrative only. A much larger repurchase program is not Micron guidance.

9. What would make me wrong?

Risk 01
FY29–30 GM falls materially below 60%
This is the cleanest way for the thesis to fail. If the next downturn looks much more like the old cycle, normalized earnings and DCF both fall quickly.
Risk 02
HBM demand weakens
HBM's wafer intensity helps tighten conventional DRAM supply on the way up. It can work in reverse if capacity shifts back toward conventional DRAM.
Risk 03
China scales faster than expected
CXMT and YMTC are much more relevant to FY29–31 than FY27. A faster supply ramp would pressure the higher-trough thesis directly.
Risk 04
Free cash flow fails to follow EPS
If capex stays structurally above my assumptions while pricing normalizes, accounting EPS can remain impressive while cash conversion disappoints.
The single variable I would watch most closely is FY29–30 gross margin.

Conclusion

The easiest way to call Micron cheap today is to take peak FY27 EPS, apply a multiple and stop there.

I do not think that is good enough for a memory stock.

So I made the Base case harder.

I assume a real downturn.

Gross margin falls from 87% to 60%.

EPS falls from about $166 to $126.

Revenue actually declines in FY29.

And even after doing that:

Japan Stock Alpha conclusion
DCF gives me roughly $1,300

while

FY27–31 cycle-average EPS at 10x gives me roughly $1,470

against the $940.76 Aug. 18 price anchor used in this analysis.

The stock does not need 85% gross margins forever.

It needs the next trough to be less destructive than the old ones.

SCAs provide more contractual visibility.

HBM absorbs more supply capacity per bit.

The balance sheet is dramatically stronger.

And S&P's move to BBB+ / Positive is another piece of evidence that Micron's financial resilience is improving — even if it is not a direct equity catalyst.

None of that eliminates the memory cycle.

But it may change the economics of the next one.

At the price anchor used here, I think the risk/reward remains attractive.

Let's see how it goes.

Primary materials and research inputs

Micron Q3 FY26 earnings release and prepared remarks; Micron SEC filings; Micron management commentary at the August 2026 KeyBanc conference; S&P Global Ratings; public analyst commentary and estimates from Morgan Stanley, Barclays, UBS, Bernstein and Morningstar; and the Japan Stock Alpha Micron valuation model. Company-reported facts, analyst estimates and Japan Stock Alpha assumptions are treated separately in the article.

Research tool used in this analysis

Fiscal.ai was used as one of the research tools for collecting and reviewing financial data, company filings, earnings materials and segment information for this deep dive. We independently review the assumptions and check material figures against official company disclosures.

Explore Fiscal.ai → Code: JSAJAPAN

15% off on all payments within the first 11 months.

Disclosure: This is an affiliate link. Japan Stock Alpha may earn a commission at no extra cost to you. Always verify material figures against the company’s latest official filings.

For informational purposes only. This is not investment advice or a recommendation to buy, sell or hold any security. The $940.76 share price is a dated comparison point from 18 August 2026, not a live quote. FY27–FY31 revenue, gross margin, EPS, free-cash-flow forecasts, DCF outputs, cycle-average P/E values and sensitivity cases are Japan Stock Alpha estimates. Memory pricing, AI demand, HBM mix, supply additions, China capacity, technology execution, capital expenditure, interest rates and market valuation multiples can change materially. Always verify company-reported figures against Micron's latest official filings and conduct your own research.